Cargando…
A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms
Sworder et al.(1) developed an integrated simultaneous tumor and effector profiling (STEP) approach to study resistance mechanisms to CD19-CAR T cell therapy in large B-cell lymphomas. Their study provides novel biological insights and paves the way for future interventions.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975327/ https://www.ncbi.nlm.nih.gov/pubmed/36812888 http://dx.doi.org/10.1016/j.xcrm.2023.100949 |